Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

Objectives: To explore the epidemiological information, clinical characteristics, therapeutic outcomes and temporal progression of laboratory findings in 2019-coronavirus disease (COVID-19) patients exposed to lopinavir. Methods: We collected data from ten COVID-19 patients admitted between January...

Full description

Bibliographic Details
Main Authors: Fang Liu, Aifang Xu, Yan Zhang, Weiling Xuan, Tingbo Yan, Kenv Pan, Wenyan Yu, Jun Zhang
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:International Journal of Infectious Diseases
Subjects:
2019-Coronavirus disease
Lopinavir
Asymptomatic infection
Eosinophil
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220301326

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220301326

Similar Items